OptimizeRx Corp.
OPRX
NASDAQ·Healthcare·Medical - Healthcare Information Services·Mkt cap $147.7M
$7.87
▼ -1.01%
P/E
32.79
Mkt Cap
$147.7M
52-Wk Range
$4.54–$22.25
52-Week Range
$4.54 - $22.25
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 57.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Embedded EMR and eRx integration creating high switching costs and recurring revenue
- HIPAA-compliant cloud infrastructure with direct patient engagement capabilities
- Real-world data analytics enabling precision physician targeting and patient identification
- Multi-stakeholder network effects across pharma manufacturers, providers, and patients
- Proprietary drug file integration and sales force enablement expertise
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Increasing pharmaceutical industry adoption of digital patient engagement and eRx solutions
Value
Deep value opportunity - significant discount to Healthcare IT & Services peers
Momentum
Hot
+55.8% over 3m
Quality
Excellent
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying OPRX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 12, 2026
Reported EPS of $0.16 vs $0.11 consensus (+44.0% surprise). Revenue of $20.5M vs $20.2M expected (+1.5%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+44.0%
Revenue trend · last 8Q
—
+14%
+11%
+55%
+22%
-0%
-10%
-30%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$21.3M
$32.3M
$21.9M
$29.2M
$26.1M
$32.2M
$19.8M
$20.5M
Margins · last 8Q
Gross
81.7%
Operating
-0.4%
Profit
-8.7%
Wall Street consensus
5 analysts · 80% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
80%
Hold
20%
Sell
0%
Median Price Target
—
Latest: Citi · Aug 14, 2026
vs Industry
How OPRX stacks vs Medical - Healthcare Information Services
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related